TapImmune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TapImmune and buy or sell other stocks, ETFs, and their options commission-free!About TPIV
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEOJuan F. Vera, MD
CEOJuan F. Vera, MD
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded1991
Founded1991
Employees—
Employees—
TPIV Key Statistics
Market cap23.68M
Market cap23.68M
Price-Earnings ratio-1.16
Price-Earnings ratio-1.16
Dividend yield—
Dividend yield—
Average volume346.30K
Average volume346.30K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.95
52 Week high$5.95
52 Week low$0.8099
52 Week low$0.8099
Stock Snapshot
The current TapImmune(TPIV) stock price is $2.55, with a market capitalization of 23.68M. The stock trades at a price-to-earnings (P/E) ratio of -1.16.
TapImmune(TPIV) stock opened on 2025-12-09 at —. The price climbed to — and dipped to —.
TapImmune(TPIV) shares are trading with a volume of 0, against a daily average of 346.3K.
During the past year, TapImmune(TPIV) stock moved between $0.81 at its lowest and $5.95 at its peak.
During the past year, TapImmune(TPIV) stock moved between $0.81 at its lowest and $5.95 at its peak.